Concession for Printing and Marketing of the British Pharmacopoeia
A Contract Addendum Notice
by MHRA
- Source
- Find a Tender
- Type
- Contract (Services)
- Duration
- 5 year (est.)
- Value
- ___
- Sector
- BUSINESS
- Published
- 13 May 2022
- Delivery
- To 23 May 2027 (est.)
- Deadline
- n/a
Concepts
- british pharmacopoeia
- publishing services
- research.the british pharmacopoeia
- british pharmacopoeia commission secretariat of the medicines and healthcare products regulatory agency
- british pharmacopoeia commission secretariat of the medicines
- marketing of the british pharmacopoeia
- concession
- marketing
- printing
- medicines and healthcare products regulatory agency
Location
London
1 buyer
- MHRA London
Description
The Medicines and Healthcare products Regulatory Agency (the Agency) is an Executive Agency of the Department of Health. We protect and improve the health of millions of people every day through the effective regulation of medicines and medical devices, underpinned by science and research.The British Pharmacopoeia (BP) is the official collection of standards for UK medicinal products and pharmaceutical substances. It is produced by the British Pharmacopoeia Commission Secretariat of the Medicines and Healthcare Products Regulatory Agency, in accordance with regulation 317(1) of the Human Medicines Regulations 2012, and makes an important contribution to public health by setting publicly available standards for the quality of medicines.The Agency requires the appointment of a Concessionaire to be responsible for the printing, publishing, distribution, marketing and selling of the BP and BAN publications.
Ammendments to Previous Notice
2. IV.2.2.1 Deadline for EOI date
2022-05-23 2022-06-17 12:00
CPV Codes
- 79970000 - Publishing services
Reference
- FTS 012546-2022